You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美銀證:上調復星醫藥(2196.HK)目標價至33港元 評級維持買入
格隆匯 04-16 14:16

美銀證券發表報告指,原先預期復星醫藥(2196.HK)今年上半年受新型肺炎疫情影響,將僅錄低單位數增長。惟該股過去數週累升20%,主要由於復星醫藥或透過多種新型肺炎相關產品受惠所致。

該行認為,復星醫藥今明兩年銷售表現仍將受到疫情影響,惟上調2022年後之銷售增速,由於部份創新藥有機會獲批。該行調整復星醫藥開支、資本開支及營運資本之預測,降今明兩年每股盈利預測分別11%及7%,大幅上調2022年每股盈利預測1.4倍,目標價自28港元上調至33港元,評級維持“買入”。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account